GLPwatch

Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet.

Int J Obes (Lond) · 2010

Last updated 2026-05-28

In a study on mice fed a high-fat diet, daily treatment with the GLP-1 drug exendin-4 (25 nmol per kg of body weight, twice daily for 21 days) improved blood sugar control and enhanced learning and memory, as shown by a higher recognition index. The high-fat diet had previously reduced the brain's ability to strengthen connections (long-term potentiation), but this effect was reversed with exendin-4 treatment.

AI summary of the abstract below.

JournalInt J Obes (Lond), 2010
Citations81
Relative citation ratio2.42
NIH percentile79
Molecules
Conditions studied Alzheimers, Type 2 Diabetes, Obesity

Abstract

High-calorie diet has been shown to impair learning ability and hippocampal synaptic plasticity in rodents. This study examined effects of daily treatment with the glucagon-like peptide-1 mimetic, exendin-4, on cognitive function and hippocampal synaptic plasticity in a model of diet-induced obesity, which exhibits compromised cognitive performance. Mice fed a high-fat diet were treated with exendin-4 (25 nmol kg(-1) bodyweight; twice daily) or saline vehicle (0.9% (w/v) NaCl) over 21 days. In addition to improving metabolic control, exendin-4-treated mice exhibited a marked increase in recognition index highlighting improved learning and memory. High-fat diet resulted in the elimination of in vivo electrophysiological long-term potentiation, which was rescued following exendin-4 treatment. This study shows that exendin-4 therapy improves cognitive function and ameliorates impaired hippocampal synaptic plasticity in dietary-induced obesity.

Verbatim abstract via PubMed 20351729 ↗